Invention Grant
- Patent Title: Piperazinyl methanone NAAA inhibitors
-
Application No.: US16301200Application Date: 2017-05-16
-
Publication No.: US10556892B2Publication Date: 2020-02-11
- Inventor: Daniele Piomelli , Rita Scarpelli , Marco Migliore , Roger Heim , Miguel Garcia-Guzmàn
- Applicant: The Regents of the University of California , Fondazione Istituto Italiano Di Tecnologia
- Applicant Address: US CA Oakland IT Genoa
- Assignee: The Regents of the University of California,Fondazione Istituto Italiano di Technologia
- Current Assignee: The Regents of the University of California,Fondazione Istituto Italiano di Technologia
- Current Assignee Address: US CA Oakland IT Genoa
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Edward D. Grieff
- International Application: PCT/US2017/032981 WO 20170516
- International Announcement: WO2017/201103 WO 20171123
- Main IPC: C07D417/04
- IPC: C07D417/04 ; C07D413/04 ; C07D417/14 ; A61P25/28 ; A61P25/16
Abstract:
Disclosed herein, inter alia, are compositions and methods for modulating the activity of N-acylethanolamine acid amidase for the treatment of a pathological state, including pain, an inflammatory condition, or a neurodegenerative disorder.
Public/Granted literature
- US20190177313A1 PIPERZINYL METHANONE NAAA INHIBITORS Public/Granted day:2019-06-13
Information query
